Chinese Role in U.S. Cannabis and Hemp Markets: Investigations and Policy
This hub tracks scrutiny of Chinese involvement in the U.S. cannabis and hemp industries. It covers the October 2026 call by Republican senators for a Department of Justice investigation, along with the issues behind it: illicit grow operations in states such as Oklahoma, California, and Maine, foreign ownership of farmland, and dependence on imported vape hardware and cultivation equipment. It explains how federal law treats marijuana and hemp differently, which agencies have jurisdiction, and what state-level responses exist. We update the page as investigations, legislation, and enforcement actions develop.

Executive summary
Republican senators have asked the Department of Justice to investigate Chinese involvement in the U.S. hemp and cannabis markets, a request that arrives six weeks before the federal hemp redefinition takes effect. The Hill reported the call on October 1, 2026. This hub covers the background, the legal tools available, the state-level record, and what the push means for operators and investors.
The concerns fall into four categories. The first is illegal grows in states such as Oklahoma, Maine, Oregon and California, which officials have linked to organized criminal networks with Chinese ties. The second is dependence on Chinese-made hardware, including vape cartridges, batteries, lighting, extraction equipment and packaging. The third is Chinese-origin hemp, cannabinoid inputs and synthesized cannabinoids that move through the post-2018 Farm Bill hemp channel. The fourth is foreign ownership, financing and money laundering through license "straw" structures.
The federal legal landscape is split. Marijuana remains a Schedule I controlled substance under 21 U.S.C. § 812 unless and until rescheduling is finalized. Hemp is legal under the 2018 Farm Bill (7 U.S.C. § 1639o et seq.) but faces a sweeping redefinition enacted in November 2025. DOJ has criminal tools at hand: the Controlled Substances Act, money laundering statutes, and the Bank Secrecy Act. The Committee on Foreign Investment in the United States (CFIUS) covers some transactions. State foreign-ownership laws add another layer.
This page does not reproduce the senators' letter. We have only the headline and publication details of The Hill's report, so the letter's signatories and specific requests will be added as dated updates once the primary document is confirmed. Everything below is background drawn from statutes, agency records and prior public reporting.
Why this matters
The investigation call touches every layer of a market that is both federally illegal (marijuana) and federally ambiguous (hemp), so any enforcement turn shifts costs, supply chains and licensing risk at once.
Several stakeholder groups are exposed.
- Licensed operators and MSOs. Multi-state operators already pay an effective federal tax penalty under 280E, and they depend on imported hardware. Tariffs or import restrictions on Chinese components raise their input costs directly. A foreign-ownership enforcement wave could also force license-transfer reviews.
- Hemp processors and retailers. The hemp-derived intoxicating-products market, including THCA flower and synthesized cannabinoids, faces a federal definition change that takes effect on November 12, 2026. A China-focused DOJ inquiry gives backers of that restriction a national-security argument.
- Patients. Medical programs in states such as Oklahoma, Ohio and Florida rely on a licensed supply chain. Enforcement against illicit grows tends to remove product from the unlicensed market, but diversion and license revocations can also disrupt supply.
- Local communities. Rural counties have described water theft, labor trafficking concerns and fire and electrical hazards at illegal grow sites. At the same time, Asian American residents and growers face a real risk of ethnic profiling in enforcement.
- Investors and lenders. Banks, landlords and equipment lessors need to know their counterparties' ownership. Clearer federal scrutiny increases know-your-customer burdens in a sector where the Corporate Transparency Act's beneficial-ownership reporting was narrowed for domestic companies in 2025.
We have no verified national dollar estimate for Chinese-linked cannabis revenue, and none should be assumed. Claims of that kind circulate widely, but they typically rest on enforcement seizures in specific states rather than a market-wide measurement. We flag figures only when a named agency published them.
Background and history
The current debate sits at the intersection of three timelines: state medical-cannabis licensing, federal hemp legalization, and a decade of tightening U.S.-China economic scrutiny.
1970: The Controlled Substances Act sets the baseline
The Controlled Substances Act placed marijuana in Schedule I, codified at 21 U.S.C. § 812. The statutory definition of "marihuana" in 21 U.S.C. § 802(16) originally covered the entire Cannabis sativa L. plant, hemp included. That single definition is the reason hemp needed a separate act of Congress to become legal.
1996 to 2014: State programs grow, hardware globalizes
California legalized medical cannabis in 1996. By the early 2010s, dozens of states had followed, and Colorado and Washington opened adult-use markets in 2014. As those markets grew, a global supply chain formed for lights, vaporizers and packaging, with much of the electronic hardware manufactured in Shenzhen and surrounding Guangdong province. Chinese firms such as Smoore International became major producers of vaporizer components. This hardware dependence is the oldest and least contested link between China and the U.S. cannabis industry.
2014: Farm Bill pilot programs
Section 7606 of the 2014 Farm Bill allowed state agriculture departments and universities to run hemp research pilots. Operators began importing hemp seed and genetics, and the first modern CBD market took shape. China had long been among the world's largest hemp fiber producers, and Chinese-origin extracts and cannabinoid inputs entered global trade.
2018: The Agriculture Improvement Act
The 2018 Farm Bill removed hemp, defined as Cannabis sativa L. with no more than 0.3 percent delta-9 THC on a dry-weight basis, from the Controlled Substances Act. USDA took over licensing and published its hemp rule at 7 C.F.R. Part 990. The statute did not address derivatives made from hemp, such as delta-8 THC and THCA flower. Those products multiplied and became the core of the intoxicating hemp market. FDA retained authority over foods, drugs and dietary supplements and has never approved CBD as an additive.
2018: CFIUS expands
The Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA) widened CFIUS jurisdiction to cover certain real estate transactions and minority investments in sensitive U.S. businesses. Cannabis assets are not a core CFIUS category, but FIRRMA's real-estate authority, and the political attention it generated, shaped later state and federal efforts to limit foreign ownership of land.
2021 to 2024: Illegal grows draw attention
After Oklahoma's 2018 medical-marijuana ballot measure (State Question 788) created one of the least restrictive licensing regimes in the country, the state saw a surge in licensed and unlicensed grows. Oklahoma officials, including Attorney General Gentner Drummond and Governor Kevin Stitt, publicly tied a portion of the activity to out-of-state and foreign-linked criminal operators. The state imposed a moratorium on new commercial licenses in 2022 and later added ownership-verification and enforcement measures. The Oklahoma Bureau of Narcotics and the Oklahoma Medical Marijuana Authority became the principal enforcement bodies.
Similar cases emerged in Maine, Oregon and California. Local sheriffs and state officials described illegal grows operating in residential and rural properties and sometimes involving labor exploitation. Reporting on these cases also documented the risk of profiling, and civil rights complaints followed in places such as California's Siskiyou County. This tension runs through the entire debate.
2023: States restrict foreign ownership
Florida's SB 264 (2023) limited property purchases by entities domiciled in "countries of concern," including China. Arkansas Attorney General Tim Griffin ordered Chinese-owned Syngenta to divest Arkansas farmland in October 2023. Texas followed in 2025 with SB 17, restricting land acquisition by entities tied to China, Iran, North Korea and Russia. These laws do not target cannabis specifically, but they reach grow-site land and agricultural property.
2025: Tariffs, hemp redefinition and rescheduling
New tariffs on Chinese imports in 2025 raised costs for vape hardware, packaging and grow equipment. In March 2025, FinCEN issued an interim final rule exempting U.S.-formed companies from beneficial-ownership reporting under the Corporate Transparency Act, which narrowed one transparency tool.
In November 2025, Congress enacted an agriculture appropriations provision that redefined hemp to exclude products with more than trace total THC per container and to exclude synthesized cannabinoids. The provision takes effect one year after enactment, on November 12, 2026. In December 2025, President Trump signed an executive order directing the Attorney General to move forward on rescheduling marijuana to Schedule III. The DEA rulemaking process, including the earlier NPRM and stalled ALJ hearing, is tracked on our rescheduling hub.
October 2026: The Senate call
On October 1, 2026, The Hill reported that GOP senators called on DOJ to investigate the Chinese role in hemp and cannabis markets. The timing lands just ahead of the hemp redefinition's effective date and amid the unresolved rescheduling process.
| Year | Milestone | Relevance |
|---|---|---|
| 1970 | Controlled Substances Act | Marijuana Schedule I, 21 U.S.C. § 812 |
| 2014 | Farm Bill § 7606 pilots | Hemp research programs open import channels |
| 2018 | Agriculture Improvement Act; FIRRMA | Hemp legalized at 0.3% delta-9 THC; CFIUS expanded |
| 2022 | Oklahoma license moratorium | Response to grow proliferation |